Historical Stock Price
ETFs Holding SSRI »    Stock Splits Calendar »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
07/27/2017 $9.88 $9.88 $9.56 $9.63 1.63M
07/28/2017 $9.69 $9.85 $9.66 $9.78 1.08M
07/31/2017 $9.72 $9.89 $9.61 $9.73 1.01M
08/01/2017 $9.66 $9.83 $9.59 $9.71 1.12M
08/02/2017 $9.66 $9.76 $9.56 $9.56 803.70K
SSR Mining is engaged in the acquisition, exploration, development and operation of silver-dominant resource properties located in the Americas. Co.'s strategic focus is to optimize the production of silver from its Pirquitas mine in Argentina, and to advance other principal development and exploration projects including San Luis in Peru, Diablillos in Argentina, and Pitarrilla and San Agustin in Mexico. In addition to its principal projects, Co. holds a geologically-diverse portfolio of other predominantly silver projects in various stages of exploration.
SSRI historical stock prices picture
SSRI (SSRI) has the following price history information. Looking back at SSRI historical stock prices for the last five trading days, on July 27, 2017, SSRI opened at $9.88, traded as high as $9.88 and as low as $9.56, and closed at $9.63. Trading volume was a total of 1.63M shares. On July 28, 2017, SSRI opened at $9.69, traded as high as $9.85 and as low as $9.66, and closed at $9.78. Trading volume was a total of 1.08M shares. On July 31, 2017, SSRI opened at $9.72, traded as high as $9.89 and as low as $9.61, and closed at $9.73. Trading volume was a total of 1.01M shares. On August 01, 2017, SSRI opened at $9.66, traded as high as $9.83 and as low as $9.59, and closed at $9.71. Trading volume was a total of 1.12M shares. On August 02, 2017, SSRI opened at $9.66, traded as high as $9.76 and as low as $9.56, and closed at $9.56. Trading volume was a total of 803.70K shares.

SSRI Historical Stock Prices By Date:

SSRI historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into SSRI shares, starting with a $10,000 purchase of SSRI, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/20/2009
End date: 08/02/2017
Start price/share: $15.52
End price/share: $9.56
Dividends collected/share: $0.00
Total return: -38.40%
Average Annual Total Return: -5.68%
Starting investment: $10,000.00
Ending investment: $6,158.22
Years: 8.29
Date Close
07/27/2017$9.63
07/28/2017$9.78
07/31/2017$9.73
08/01/2017$9.71
08/02/2017$9.56
SSRI is categorized under the Materials sector; below are some other companies in the same sector:

STA Historical Stock Prices
STCK Historical Stock Prices
STH Historical Stock Prices
STLD Historical Stock Prices
SUG Historical Stock Prices
SUM Historical Stock Prices
SUTR Historical Stock Prices
SVBL Historical Stock Prices
SVG Historical Stock Prices
SVLC Historical Stock Prices

SSRI Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2019, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.